Acadian Asset Management LLC Immuno Gen, Inc. Transaction History

Acadian Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.02 - $6.59 $54,291 - $71,270	-10,815 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$5.79 - $8.6 $5,292 - $7,860	-914 Reduced 7.79%	10,815 $71,000
Q1 2021 May 11, 2021	BUY	$6.5 - $10.53 $76,238 - $123,506	11,729 New	11,729 $95,000
Q4 2020 Feb 11, 2021	SELL	$3.7 - $7.66 $104,898 - $217,168	-28,351 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$3.45 - $4.89 $488,468 - $692,350	-141,585 Reduced 83.32%	28,351 $102,000
Q2 2020 Aug 12, 2020	BUY	$3.32 - $5.34 $308,238 - $495,781	92,843 Added 120.43%	169,936 $781,000
Q1 2020 May 11, 2020	SELL	$2.12 - $6.8 $213,615 - $685,181	-100,762 Reduced 56.65%	77,093 $263,000
Q4 2019 Feb 06, 2020	SELL	$2.25 - $5.8 $26,194 - $67,523	-11,642 Reduced 6.14%	177,855 $908,000
Q3 2019 Nov 07, 2019	BUY	$2.22 - $3.39 $420,683 - $642,394	189,497 New	189,497 $459,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.